Project Details
Project Description
Contract research for Sanofi-aventis Australia Pty Limited examining the incidence, severity and remission rates of eczema from infancy to adulthood in the Melbourne Atopic Cohort Study (MACS).
The aim is to measure the prevalence , incidence, as well as the severity and remission rates of eczema among Australians. Specifically we will:
(i) Identify the lifetime, 6-and 12-months period-prevalence of eczema.
(ii) determine incident eczema at at ages: 6 months, 1, 2, 6, 12, 18, 43 and 67 years.
(iii) determine the severity of eczema
The aim is to measure the prevalence , incidence, as well as the severity and remission rates of eczema among Australians. Specifically we will:
(i) Identify the lifetime, 6-and 12-months period-prevalence of eczema.
(ii) determine incident eczema at at ages: 6 months, 1, 2, 6, 12, 18, 43 and 67 years.
(iii) determine the severity of eczema
| Short title | Epidemiology of Eczema |
|---|---|
| Status | Finished |
| Effective start/end date | 3/07/21 → 3/07/22 |